PHARMABEES vs M&MFIN: Stock Comparison
Head-to-head financial and trading comparison between PHARMABEES (PHARMABEES) and Mahindra & Mahindra Financial Services Limited (M&MFIN) in the Cross-Sector Peers sector.
PHARMABEES
NSE: PHARMABEESM&MFIN
NSE: M&MFINKey Metrics Comparison Table
| Metric | PHARMABEES | M&MFIN | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹26.72 | ₹319.45 | — |
| 1-Year Price Return | +16.07% | +5.22% | PHARMABEES (10.85% higher) |
| 52-Week High | ₹27.89 | ₹412.30 | — |
| 52-Week Low | ₹23.00 | ₹275.70 | — |
| 30-Day Annualized Volatility | 14.23% | 26.44% | PHARMABEES (Steadier) |
| 30-Day Average Daily Volume | 4,400,662 | 1,848,112 | PHARMABEES (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PHARMABEES and M&MFIN, which stock gave better returns over the last year?
PHARMABEES has outperformed M&MFIN over the past 12 months with a gain of 16.07% compared to 5.22%.
Which stock is less volatile: PHARMABEES or M&MFIN?
PHARMABEES demonstrated lower price volatility (14.23% annualized) compared to M&MFIN (26.44%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PHARMABEES vs M&MFIN?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PHARMABEES and M&MFIN direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.